Luis Martin

6PUBLICATIONS
10CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsNanomaterialsInnate immunityHorticultural crop improvement (incl. selection and breeding)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 Variants.

|Jan 13, 2021
Modulation of Antigen Display on PapMV Nanoparticles Influences Its Immunogenicity.

Marie-Eve Laliberté-Gagné, Marilène Bolduc, Caroline Garneau

|Nov 07, 2020
Rapid High-Yield Production of Functional SARS-CoV-2 Receptor Binding Domain by Viral and Non-Viral Transient Expression for Pre-Clinical Evaluation.

Omar Farnós, Alina Venereo-Sánchez, Xingge Xu

|Jul 24, 2020
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age.

Joanne Langley, Elodie Pastural, Scott Halperin

|Jul 20, 2017
A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling.

Ariane Thérien, Mikaël Bédard, Damien Carignan

|Jun 11, 2016
Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine.

Gervais Rioux, Damien Carignan, Alexis Russell

Pageof 1

Frequent Collaborators

2 joint publications

Santa-Mariela Olivera-Ugarte

1 joint publications

Omar Farnós

1 joint publications

Uri Saragovi

1 joint publications

Léa-J Blanchette